36 results
8-K
EX-10.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
of independent Public Company Accounting Oversight Board (PCAOB) registered public accountants for a period of at least five (5) years after the Closing Date
424B3
7arcm4
4 Apr 23
Prospectus supplement
4:57pm
POS AM
wy2n ssnp
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-10.1
enklg1qm
16 May 22
Entry into a Material Definitive Agreement
9:49pm
PRE 14A
twj55k dle3wrljy5f4
21 Apr 22
Preliminary proxy
4:33pm
424B4
7ewyzla
17 Jun 21
Prospectus supplement with pricing info
4:31pm